Education
About Us
Working with TipRanks
Follow Us
Maykin Ho Insider Profile
4 Followers
Maykin Ho, Director at Parexel, holds 17.03K shares in Agios Pharma (Ticker: AGIO), holds 28.01K shares in BioMarin Pharmaceutical (Ticker: BMRN), holds 20.10K shares in Neumora Therapeutics, Inc. (Ticker: NMRA).
Maykin Ho Parexel (PRXL)Director
Parexel (PRXL)
Director
Not Ranked
Maykin Ho has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Maykin Ho holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Maykin Ho
Maykin Ho's Trading History
Parexel
Oct 04, 2017
―
Uninformative Sell
―
$213.15K
FibroGen
Jun 09, 2023
Director
Uninformative Sell
148.59K
$330.13K
BioMarin Pharmaceutical
May 22, 2025
Director
Uninformative Buy
―
$1.64M
Neumora Therapeutics, Inc.
Jun 14, 2024
Director
Uninformative Buy
―
$35.38K
Agios Pharma
Jun 23, 2025
Director
Uninformative Buy
72.95K
$668.85K
List of latest transactions for each holding click on a transaction to see Maykin Ho's performance on stock
You May Also Like
Maykin Ho insider profile FAQ
What is the percentage of profitable transactions made by Maykin Ho?
The percentage of profitable transactions made by Maykin Ho is ―.
What is the average return per transaction made by Maykin Ho?
The average return per transaction made by Maykin Ho is ―.
What stocks does Maykin Ho hold?
Maykin Ho holds: PRXL, FGEN, BMRN, NMRA, AGIO stocks.
What was Maykin Ho’s latest transaction?
Maykin Ho latest transaction was an Uninformative Buy of $72.95K.
What was Maykin Ho's most profitable transaction?
Maykin Ho’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Maykin Ho's role in Parexel?
Maykin Ho's role in Parexel is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.